肾移植中肾素-血管紧张素系统抑制剂：效益-风险评估 - Suppr

Suppr

超能文献

Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.

作者信息

Ponticelli Claudio, Cucchiari David

机构信息

Humanitas Clinical and Research Center, via Manzoni 56, 20089, Rozzano, MI, Italy.

出版信息

J Nephrol. 2017 Apr;30(2):155-157. doi: 10.1007/s40620-017-0378-x. Epub 2017 Feb 17.

DOI:10.1007/s40620-017-0378-x

PMID:28211033

Abstract

摘要

相似文献

Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.

J Nephrol. 2017 Apr;30(2):155-157. doi: 10.1007/s40620-017-0378-x. Epub 2017 Feb 17.

The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.

Trials. 2015 Dec 19;16:581. doi: 10.1186/s13063-015-1100-8.

[Dual blockade of the renin-angiotensin system in hypertensive treatment: no].

Dtsch Med Wochenschr. 2012 Nov;137(48):2499. doi: 10.1055/s-0032-1327302. Epub 2012 Nov 20.

Inhibitors of the renin angiotensin system: proven benefits, unproven safety.

Ann Intern Med. 2008 Jan 1;148(1):76-7. doi: 10.7326/0003-4819-148-1-200801010-00191. Epub 2007 Nov 5.

Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?

Curr Opin Nephrol Hypertens. 2014 Sep;23(5):449-55. doi: 10.1097/MNH.0000000000000043.

[Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].

Dtsch Med Wochenschr. 2012 Nov;137(48):2498. doi: 10.1055/s-0032-1327303. Epub 2012 Nov 20.

Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.

South Med J. 2009 Dec;102(12):1201-2. doi: 10.1097/SMJ.0b013e3181bef7bd.

Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry.

BMC Cardiovasc Disord. 2016 Mar 8;16:56. doi: 10.1186/s12872-016-0222-6.

[Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].

Dtsch Med Wochenschr. 2010 May;135(3):98. doi: 10.1055/s-0029-1244825. Epub 2010 Jan 14.

Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.

Nat Rev Cardiol. 2013 Apr;10(4):183-4. doi: 10.1038/nrcardio.2013.28. Epub 2013 Mar 12.

引用本文的文献

Kidney Toxicity of Drugs for the Heart: An Updated Perspective.

Metabolites. 2025 Mar 11;15(3):191. doi: 10.3390/metabo15030191.

Kidney disease in non-kidney solid organ transplantation.

World J Transplant. 2022 Aug 18;12(8):231-249. doi: 10.5500/wjt.v12.i8.231.

Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden.

J Pers Med. 2022 Jul 23;12(8):1200. doi: 10.3390/jpm12081200.

Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients.

Rev Endocr Metab Disord. 2021 Dec;22(4):1157-1170. doi: 10.1007/s11154-021-09677-7. Epub 2021 Jul 22.

Prevention of complications from use of conventional immunosuppressants: a critical review.

J Nephrol. 2019 Dec;32(6):851-870. doi: 10.1007/s40620-019-00602-5. Epub 2019 Mar 29.

Cardiovascular risk in renal transplant recipients.

J Nephrol. 2019 Jun;32(3):389-399. doi: 10.1007/s40620-018-0549-4. Epub 2018 Nov 7.

Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice.

J Nephrol. 2018 Oct;31(5):653-664. doi: 10.1007/s40620-018-0502-6. Epub 2018 Jun 7.

Acute and chronic effects of metabolic acidosis on renal function and structure.

J Nephrol. 2018 Aug;31(4):551-559. doi: 10.1007/s40620-018-0493-3. Epub 2018 Apr 26.

本文引用的文献

The Effect of Renin-angiotensin System Inhibitors on Kidney Allograft Survival: A Systematic Review and Meta-analysis.

N Am J Med Sci. 2016 Jul;8(7):291-6. doi: 10.4103/1947-2714.187141.

Transplantation: The role of RAAS blockade in kidney transplantation.

Nat Rev Nephrol. 2016 Mar;12(3):129-31. doi: 10.1038/nrneph.2015.201. Epub 2015 Dec 14.

Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.

Lancet Diabetes Endocrinol. 2016 Apr;4(4):318-26. doi: 10.1016/S2213-8587(15)00368-X. Epub 2015 Oct 23.

Pathogenesis of calcineurin inhibitor-induced hypertension.

J Nephrol. 2012 May-Jun;25(3):269-75. doi: 10.5301/jn.5000174.

The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension.

Nat Med. 2011 Oct 2;17(10):1304-9. doi: 10.1038/nm.2497.

Hypertension in kidney transplant recipients.

Transpl Int. 2011 Jun;24(6):523-33. doi: 10.1111/j.1432-2277.2011.01242.x. Epub 2011 Mar 8.

KDIGO clinical practice guideline for the care of kidney transplant recipients.

Am J Transplant. 2009 Nov;9 Suppl 3:S1-155. doi: 10.1111/j.1600-6143.2009.02834.x.

Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials.

Transplantation. 2009 Jul 15;88(1):7-18. doi: 10.1097/TP.0b013e3181a9e960.

Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence.

Am J Transplant. 2007 Oct;7(10):2350-60. doi: 10.1111/j.1600-6143.2007.01928.x.

Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.

Transplantation. 2001 Dec 15;72(11):1787-92. doi: 10.1097/00007890-200112150-00013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验